Patents by Inventor Gerardo Raul Vasta

Gerardo Raul Vasta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and assay for determining methylation of GAL3 promoter for early diagnosis of prostate cancer
    Patent number: 8268549
    Abstract: A method and assay are described for determining prostate cancer and the general stage of progression of such cancer by quantifying levels of promoter methylation of gal-3, optionally in combination with the quantification of the level of GSTP1 promoter methylation, where the method and assay are non-invasive to a subject and can detect any of Stages I-IV prostate cancer.
    Type: Grant
    Filed: April 7, 2009
    Date of Patent: September 18, 2012
    Assignee: University of Maryland, Baltimore
    Inventors: Hafiz Ahmed, Gerardo Raul Vasta
  • TRANSFECTION SYSTEM FOR PERKINSUS SPECIES
    Publication number: 20100093062
    Abstract: A Perkinsus heterologous expression system that is useful to produce recombinant proteins, e.g., from related parasites of medical and veterinary relevance. This expression system increases the number of genes that can be targeted for protein structure/function studies, production of antigens, and in vitro drug screening. Also described is a transfection system for Perkinsus species, including a transfection vector expressing heterologous DNA encoding one or more Apicomplexa proteins.
    Type: Application
    Filed: March 17, 2008
    Publication date: April 15, 2010
    Applicant: UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE
    Inventors: Jose-Antonio Fernandez-Robledo, Gerardo Raul Vasta
  • METHOD AND ASSAY FOR EARLY DIAGNOSIS OF PROSTATE CANCER
    Publication number: 20090215066
    Abstract: A method and assay are described for determining prostate cancer and the general stage of progression of such cancer by quantifying levels of promoter methylation of gal-3, optionally in combination with the quantification of the level of GSTP1 promoter methylation, where the method and assay are non-invasive to a subject and can detect any of Stages I-IV prostate cancer.
    Type: Application
    Filed: April 7, 2009
    Publication date: August 27, 2009
    Applicant: UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE
    Inventors: Hafiz Ahmed, Gerardo Raul Vasta